A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2009
12/23/2009	CA2727911A1 Phenyl-alkyl piperazines having a modulating activity of tnf
12/23/2009	CA2727908A1 Pharmaceutical composition comprising a 4-hydroxy-2-oxo-2, 3- dihydro-1, 3-benzothiazol-7-yl compound for modulation of beta2-adrenoreceptor activity
12/23/2009	CA2727889A1 Anti-tumour compositions and methods
12/23/2009	CA2727626A1 Novel derivatives of pyrroloindole inhibitors of hsp90, compositions containing same, and use thereof
12/23/2009	CA2727428A1 Drug carrier
12/23/2009	CA2727362A1 New trinem antibiotics and inhibitors of beta-lactamases
12/23/2009	CA2727251A1 2 -arylaminoquinazolines for treating proliferative diseases
12/23/2009	CA2727195A1 Use of runx3 and mir-532-5p as cancer markers and therapeutic targets
12/23/2009	CA2727155A1 Anti-inflammatory analgesic external preparation
12/23/2009	CA2727154A1 Oxybuprocaine-containing analgesic/antipruritic external preparation
12/23/2009	CA2727069A1 Thiophene or thiazole derivatives and their use as pi3k inhibitors
12/23/2009	CA2727064A1 Combination of pilocarpin and methimazol for treating charcot-marietooth disease and related disorders
12/23/2009	CA2727036A1 Triazolopyridine jak inhibitor compounds and methods
12/23/2009	CA2727021A1 Process for purifying rasagiline base
12/23/2009	CA2727017A1 Process for preparing and drying solid rasagiline base
12/23/2009	CA2726844A1 Triazolopyridine jak inhibitor compounds and methods
12/23/2009	CA2726746A1 Benzoxazinone derivatives acting as beta2-adrenoreceptor agonist for the treatment of respiratory disorders
12/23/2009	CA2726703A1 Heteroaromatic monoamides as orexinin receptor antagonists
12/23/2009	CA2726611A1 Process for the preparation of rho-kinase inhibitor compounds
12/23/2009	CA2726529A1 Use of zinc chelators to inhibit biofilm formation
12/23/2009	CA2726508A1 Pyridine compounds
12/23/2009	CA2726337A1 Pharmaceutical formulations and methods of use which combine non-steroidal anti-inflammatory compounds with anti-hypertensive compounds
12/23/2009	CA2726187A1 Targeted oligonucleotide compositions for modifying gene expression
12/23/2009	CA2726164A1 Wnt protein signalling inhibitors
12/23/2009	CA2725940A1 Novel substituted azabenzoxazoles
12/23/2009	CA2725934A1 Novel substituted indoles
12/23/2009	CA2725911A1 Methods of treating a meiotic kinesin-associated disease
12/23/2009	CA2725770A1 Plant-based compositions and uses
12/23/2009	CA2725657A1 Novel heteroaryl carboxamide derivatives
12/23/2009	CA2725487A1 A pharmaceutical composition
12/23/2009	CA2725481A1 Nicotinamide derivatives
12/23/2009	CA2725014A1 Inhibitors of pi3 kinase
12/23/2009	CA2725008A1 Non-hormonal steroid modulators of nf-kb for treatment of disease
12/23/2009	CA2724998A1 Nicotinamide derivatives
12/23/2009	CA2724767A1 Synthetic analogues of phosphatidyl-myo-inositol mannosides with an inhibitory activity on the inflammatory response
12/23/2009	CA2724449A1 5-ht3 receptor modulators, methods of making, and use thereof
12/23/2009	CA2723279A1 3-substituted-1h-indole compounds, their use as mtor kinase and pi3 kinase inhibitors, and their syntheses
12/22/2009	US7635788 Alpha-amino acid derivatives with antiinflammatory activity
12/22/2009	US7635775 Analgesics; central nervous system disorders ; antiarthritic agents; inflammatory bowel disorders; 2-[2-(S or R)-1-(4-chloro-2,5-dimethylbenzenesulfonyl)-3-oxo-1,2,3,4-tetrahydroquinoxalin-2-yl]-N-[1-(R)-(pyrrolidin-N-ylcarbonyl-4-guanidino-but-1-yl]acetamide
12/22/2009	US7635774 Benzimidazole derivatives
12/22/2009	US7635773 Sulfoalkyl ether cyclodextrin compositions
12/22/2009	US7635769 Oligoribonucleotide derivatives for specific inhibition of gene expression
12/22/2009	US7635722 Chemical induced intracellular hyperthermia
12/22/2009	US7635721 Crystalline form III of agomelatine, a process for its preparation and pharmaceutical compositions containing it
12/22/2009	US7635720 Prostaglandin analog compositions to treat epithelial-related conditions
12/22/2009	US7635719 Use of adamatyl methoxydiphenyl propenoic acid for the treatment of acne
12/22/2009	US7635718 4-((phenoxyalkyl)thio)-phenoxyacetic acids and analogs
12/22/2009	US7635717 desalting Gabapentin hydrochloride to obtain Gabapentin; obtain Gabalactam from Gabapentin hydrochloride; acetone-free; chemical intermediates; drug for the treatment of epilepsy and other cerebral disorders; anticonvulsants
12/22/2009	US7635716 7-[(1R,2S,3R,5R)-2-(3,5-Bis-trifluoromethyl-phenoxymethyl)-5-chloro-3-hydroxy-cyclopentyl]-heptanoic acid; glaucoma and/or ocular hypertension
12/22/2009	US7635715 enzyme inhibitor for treating ischemia, anemia, wound healing, auto-transplantation, allo-transplantation, xeno-transplantation, systemic high blood pressure, thalassemia, diabetes, cancer, and inflammatory disorders; N-((4-hydroxy-2-oxo-6-(trifluoromethyl)-2',3',5',6'-tetrahydro-2H-spiro[naphthalene-1,4
12/22/2009	US7635714 treating constipation in a patient with 8,9-didehydro-N-demethyl-9-deoxo-6,11-dideoxy-6,9-epoxy-12-O-methyl-N-(1-methylethyl)-11-oxoerythromycin; unlike a laxative
12/22/2009	US7635713 Preterm labor, dysmenorrhea, asthma, hypertension, infertility, sexual disorders, undesired blood clotting, bone disorders, eclampsia, or eosinophil disorder; use in combination with a phosphodiesterase inhibitor; e.g. (5Z)-7-{1-[3-hydroxy-4-(3-methylphenyl)butyl]-3-oxopyrrolidin-2-yl}hept-5-enoic acid
12/22/2009	US7635712 Salinosporamides and methods for use thereof
12/22/2009	US7635711 Antiinflammatory agents; antiallergens; antiproliferative agents; 4-(5-Fluoro-2-hydroxy-phenyl)-2-hydroxy-4-methyl-2-trifluoromethyl-pentanoic acid (3,5-dichloro-phenyl)-amide
12/22/2009	US7635710 N-[2-(5-methoxy-indol-3-yl)-ethyl]-commenamide for treating diabetes type II, depression, anxiety, a sleep disorder or sleep disturbance or for improving sleep quality or for altering a circadian rhythm; dosage forms
12/22/2009	US7635709 Synergistic mixture of acetylcholinesterase inhibitor and anticholinergic agent; side effect reduction
12/22/2009	US7635708 Peroxidase proliferator activated receptor (PPAR) gamma agonists for playing key role in inducing growth arrest by terminal differentiation of actively proliferating PPAR gamma-expressing cells, particularly transformed adipose cells
12/22/2009	US7635707 Pirfenidone treatment for patients with atypical liver function
12/22/2009	US7635706 5HT4-antagonistic 4-(aminomethyl)-piperidine benzamides
12/22/2009	US7635705 Heteroatom-linked substituted piperidines and derivatives thereof useful as histamine H3 antagonists
12/22/2009	US7635704 Stable crystal of 4-oxoquinoline compound
12/22/2009	US7635703 as tyrosine, serine/threonine, cyclin-dependent kinases, HER protein; 5-{2-[3-[4-trifluoromethyl-1-(2-trimethylsilanyl-ethoxymethyl)-1H-imidazol-2-yl]-1-(2-trimethylsilanyl-ethoxymethyl)-1H-pyrazol-4-yl]-vinyl}-pyridine-3-carbaldehyde; antiproliferative, antiinflammatory agent, neurodegenerative diseases
12/22/2009	US7635702 Imidazole compounds as transforming growth factor (TGF) inhibitors
12/22/2009	US7635701 Pyrimidine derivatives and their use as CB2 modulators
12/22/2009	US7635700 5-Substituted quinazolinone derivatives and compositions comprising and methods of using the same
12/22/2009	US7635699 Azolopyrimidine-based inhibitors of dipeptidyl peptidase IV and methods
12/22/2009	US7635698 Compounds useful as chemokine receptor antagonists
12/22/2009	US7635697 e.g. 3-Bromo-8,11-dichloro-6,11-dihydro[5,6]cyclohepta[1,2-b]pyridine deivative; anticarcinogenic agents
12/22/2009	US7635696 dopamine D2 or D3 and serotonin 5-HT1A receptors antagonist with selective serotonin reuptake inhibition (SSRI) properties; (chromeno/quinolino/benzothiopyrano/naphthaleno)[4,3-c]isoxazol derivatives; psychosis, schizophrenia, bipolar disorder; alkylation followed by reductively amination
12/22/2009	US7635695 4-Amino-2-(4-methyl-thiophen-2-yl)thieno[3,2-c]pyridine-7-carboxylic acid amide; 4-amino-2-cyclopent-1-enyl-thieno[3,2-c]pyridine-7-carboxylic acid amide; for therapy and prophylaxis of disease or condition associated with inflammation, a metabolic disorder, infection, cancer or an immune disease
12/22/2009	US7635694 Cyclobutenedione-containing compounds as inhibitors of hepatitis C virus NS3 serine protease
12/22/2009	US7635693 Methods for preventing and treating cancer using N-thiolated β-lactam compounds and analogs thereof
12/22/2009	US7635692 In form of concentrate or dietary composition such as fortified foods, fortified feed and beverages, or in the form of different galenical formulations such as tablets, granules filled into capsules, or effervescent formulations
12/22/2009	US7635691 Use of CDP-choline for the prophylactic treatment of cerebral ischemia
12/22/2009	US7635690 HIV-1 mutations selected for by β-2′,3′-didehydro-2′,3′-dideoxy-5-fluorocytidine
12/22/2009	US7635689 Modified 2′ and 3′-nucleoside prodrugs for treating Flaviviridae infections
12/22/2009	US7635688 Gene expression vectors; intensifier dor sequence determiantion; induce immunology response; viricides
12/22/2009	US7635687 Vector system
12/22/2009	US7635685 Bifunctional antibiotics for targeting rRNA and resistance-causing enzymes and for inhibition of anthrax lethal factor
12/22/2009	US7635684 Pyrazole derivatives, medicinal composition containing the same, medicinal use thereof, and intermediate for production thereof
12/22/2009	US7635674 insulin and carrieres, a second pharmaceutical composition containing O-(3-piperidino-2-hydroxy-1-propyl)nicotinic amidoxime ( BGP-15) and carriers; prediabetic state, metabolic X-syndrome, insulin sensitivity, glucose tolerance, dislipidemia or diabetes mellitus
12/22/2009	US7635673 Gene expression inhibition via contacting with tyrphostin; liposomes; drug screening
12/22/2009	US7635491 Method for administering selenium for treating patients suffering from systemic inflammatory response syndrome (SIRS), and composition for implementing the treatment
12/22/2009	US7635490 Modified release dosage form
12/22/2009	US7635489 Delivering by oral ingestion a nutritional supplement consisting of an hyaluronic acid, or a salt or digest thereof, and a food acceptable carrier for relieving joint pain or other discomforts associated with joint disorders
12/22/2009	US7635469 Micronutrient formulations for hearing health
12/22/2009	US7635467 Mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof
12/22/2009	US7635378 Spine distraction implant and method
12/22/2009	US7635377 Spine distraction implant and method
12/22/2009	CA2567857C Irinotecan liposome formulation
12/22/2009	CA2562329C Therapeutic antimicrobial compositions and methods
12/22/2009	CA2558908C 10-deacetylbaccatine iii and 10-deacetyl 14.beta.-hydroxybaccatine iii derivatives and intermediates useful in the preparation thereof
12/22/2009	CA2538095C Selective androgen receptor modulators and methods of use thereof
12/22/2009	CA2535614C Quinazoline analogs as receptor tyrosine kinase inhibitors
12/22/2009	CA2529032C Processes for the preparation of 1-[2-benzimidazol-1-yl) quinolin-8-yl] piperidin-4-ylamine derivatives
12/22/2009	CA2523734C Pharmaceutical composition in the form of a hydrogel for transdermal administration of active ingredients
12/22/2009	CA2502269C Beta-amino heterocyclic dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes
12/22/2009	CA2487306C Novel piperidine compound
12/22/2009	CA2486859C Combination immediate release controlled release levodopa/carbidopa dosage forms
12/22/2009	CA2482447C Dual dispenser for aesthetically acceptable delivery of anhydrous skin treatment compositions

1 ... 2450 2451 2452 2453 2454 2455 2456 2457 2458 2459 2460 2461 2462 2463 2464 2465 2466 2467 2468 2469 2470 ... 7860